Vallerie V Mclaughlin

11PUBLICATIONS
64CO-AUTHORS
Respiratory diseasesClinical pharmacology and therapeuticsPharmacogenomicsNaturopathyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 08, 2026
Circulating biomarker results from a phase 2 study of seralutinib in pulmonary arterial hypertension.

|Aug 11, 2025
Seralutinib for the Treatment of Pulmonary Arterial Hypertension in Adults: TORREY Open-Label Extension Study.

Olivier Sitbon, Sandeep Sahay, Pilar Escribano Subías

|Aug 05, 2025
Characteristics of Patients with Pulmonary Arterial Hypertension Receiving Selexipag in the SPHERE Registry by Race and Ethnicity.

Harrison W Farber, Murali M Chakinala, Anna R Hemnes

|Apr 01, 2025
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.

Marc Humbert, Vallerie V McLaughlin, David B Badesch

|Nov 18, 2024
Pulmonary Hypertension: From Therapeutic Nihilism to Multiple Therapeutic Interventions.

Vallerie V McLaughlin, Marc Humbert

|Jul 10, 2024
Contemporary Treatment of Pulmonary Arterial Hypertension: A U.S. Perspective.

Sandeep Sahay, Murali M Chakinala, Nick H Kim

Pageof 2

Frequent Collaborators

4 joint publications

Raymond L Benza

4 joint publications

Robert P Frantz

4 joint publications

Kelly M Chin

3 joint publications

Hossein-Ardeschir Ghofrani